Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
425.50    5.00 (1.19%)
Bid:
425.00
Ask:
426.50
Spread: 1.50 (0.353%)
Market Cap: £1.38b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Issue of Equity

22 Mar 2022 16:42

Fidelity Special Values Plc - Issue of Equity

Fidelity Special Values Plc - Issue of Equity

PR Newswire

London, March 22

Fidelity Special Values PLC

Issue of Ordinary Shares

On 22 March 2022, Fidelity Special Values PLC (the “Company”) issued from its block listing facility of 14 December 2020, a total of 185,000 new shares, 50,000 at a price of 293.60 pence per share and 135,000 at a price of 294.00 pence per share. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, there are 1,095,000 Ordinary shares available under the Company’s block listing facility of 14 December 2020. In addition, the Company also has 30,000,000 ordinary shares under its block listing facility of 7 February 2022.

As a result of this issue, the total number of Ordinary shares in issue now stands at 323,918,920. There are no shares held in Treasury, therefore the total number of Ordinary shares with voting rights in the Company is 323,918,920.

The above figure of Ordinary shares with voting rights (323,918,920) may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Smita Amin

For and on behalf of FIL Investments International

Company Secretary

01737 836347

22 March 2022

Date   Source Headline
28th Feb 20257:45 amRNSNet Asset Value(s)
27th Feb 20255:07 pmPRNTransaction in Own Shares
27th Feb 202510:51 amPRNMonthly Factsheet
27th Feb 20257:31 amRNSNet Asset Value(s)
26th Feb 20255:49 pmPRNTransaction in Own Shares
26th Feb 20257:31 amRNSNet Asset Value(s)
25th Feb 20257:29 amRNSNet Asset Value(s)
24th Feb 20257:43 amRNSNet Asset Value(s)
21st Feb 20257:27 amRNSNet Asset Value(s)
20th Feb 20257:27 amRNSNet Asset Value(s)
19th Feb 20257:18 amRNSNet Asset Value(s)
18th Feb 20257:17 amRNSNet Asset Value(s)
17th Feb 20257:32 amRNSNet Asset Value(s)
14th Feb 20257:28 amRNSNet Asset Value(s)
13th Feb 20257:28 amRNSNet Asset Value(s)
12th Feb 20257:35 amRNSNet Asset Value(s)
11th Feb 20257:25 amRNSNet Asset Value(s)
10th Feb 20257:19 amRNSNet Asset Value(s)
7th Feb 20252:56 pmPRNBlocklisting - Interim Review
7th Feb 20257:10 amRNSNet Asset Value(s)
6th Feb 20257:32 amRNSNet Asset Value(s)
5th Feb 20257:14 amRNSNet Asset Value(s)
4th Feb 20257:37 amRNSNet Asset Value(s)
3rd Feb 20256:18 pmPRNTotal Voting Rights
3rd Feb 20257:36 amRNSNet Asset Value(s)
31st Jan 20257:32 amRNSNet Asset Value(s)
30th Jan 20257:43 amRNSNet Asset Value(s)
29th Jan 20255:20 pmPRNTransaction in Own Shares
29th Jan 20257:48 amRNSNet Asset Value(s)
28th Jan 20257:40 amRNSNet Asset Value(s)
27th Jan 20257:31 amRNSNet Asset Value(s)
24th Jan 20257:47 amRNSNet Asset Value(s)
23rd Jan 20257:21 amRNSNet Asset Value(s)
22nd Jan 20259:39 amPRNMonthly Factsheet
22nd Jan 20257:17 amRNSNet Asset Value(s)
21st Jan 20257:23 amRNSNet Asset Value(s)
20th Jan 20257:43 amRNSNet Asset Value(s)
17th Jan 20257:26 amRNSNet Asset Value(s)
16th Jan 20257:28 amRNSNet Asset Value(s)
15th Jan 20257:40 amRNSNet Asset Value(s)
14th Jan 20257:26 amRNSNet Asset Value(s)
13th Jan 20257:27 amRNSNet Asset Value(s)
10th Jan 20257:33 amRNSNet Asset Value(s)
9th Jan 20257:22 amRNSNet Asset Value(s)
8th Jan 20257:26 amRNSNet Asset Value(s)
7th Jan 20257:21 amRNSNet Asset Value(s)
6th Jan 20257:31 amRNSNet Asset Value(s)
3rd Jan 20257:31 amRNSNet Asset Value(s)
2nd Jan 20253:39 pmPRNTotal Voting Rights
2nd Jan 20258:26 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.